Modified K562 Feeder Cell Line with CD80 and mbIL-21 for NK Expansion
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for expanding natural killer (NK) cells from cord blood are limited in fold expansion and do not effectively utilize CD80 as a stimulatory factor, leading to suboptimal activation and proliferation.
Innovation Solution
Modified K562 feeder cells expressing CD80, 4-1BBL, and membrane-bound IL-21 (mbIL-21) are used to enhance NK cell activation and proliferation through a two-stage process involving lentiviral vector transduction and co-culture with NK cells.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If feeder-free methods using cytokines (IL-2, IL-15, IL-21, IL-12, IL-18) are used to expand NK cells, then high cytotoxicity and memory phenotype are achieved, but fold expansion is limited
Solution Approach 1:
The patent combines feeder-free cytokine stimulation with feeder-dependent co-stimulatory molecules (4-1BBL, OX40L, CD80) in a single culture system. This merging allows NK cells to receive both proliferative signals from cytokines and co-stimulatory signals from feeder cells, achieving both high fold expansion and maintained cytotoxicity/memory phenotype simultaneously
Solution Approach 2:
The feeder cells are engineered to express multiple functions: they provide co-stimulatory molecules (4-1BBL, OX40L, CD80) for activation and membrane-bound cytokines (IL-15, IL-21) for proliferation. This multi-functionality allows a single feeder cell system to support both expansion and functional maintenance of NK cells
2Productivity
If feeder-dependent methods with irradiated feeder cells expressing co-stimulatory ligands (4-1BBL, OX40L, IL-15, IL-21) are used, then robust expansion up to 40,000-fold is achieved, but the patent indicates suboptimal activation when CD80 is not utilized
Solution Approach 1:
The feeder cells are engineered as composite expression systems, simultaneously producing multiple co-stimulatory molecules (4-1BBL, OX40L, CD80) and membrane-bound cytokines (IL-15, IL-21). This composite approach ensures that NK cells receive comprehensive stimulation signals, achieving both robust expansion and optimal activation quality
Solution Approach 2:
The patent modifies the expression parameters of feeder cells by introducing specific transgenes (4-1BBL, OX40L, CD80, IL-15, IL-21) to change the stimulatory profile. This parameter change transforms conventional feeder cells into optimized stimulatory cells that enhance both expansion and activation quality
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The modified K562 feeder cells achieve significantly higher NK cell expansion rates, up to 34.4-fold, compared to conventional methods, maintaining a mature phenotype with high CD56 and CD16 expression, and support CAR-NK cell functionality.
Implementation Method 1
a first stage involving the preparation of materials, including a K562 cell suspension, and a medium containing a lentiviral vector carrying a co-stimulatory molecule and cytokine
Implementation Method 2
CD80 provides a crucial costimulatory signal to T cells upon its transient expression on B cells, macrophages and dendritic cells. The co-stimulatory signal helps sustain T cell responses, enhances their survival, and promotes cytokine production
Implementation Method 3
membrane-bound cytokine such as IL-15 and IL-21
Implementation Method 4
Natural killer (NK) cells play a pivotal role in the innate immune system. In the malignant context, NK cells demonstrate the ability to identify stressed cells, irrespective of neoantigen presentation and those that have lost expression of MHC class I
Data Source
AI summary
A method for generating or expanding a population of natural killer cells (NK cells) via using modified K562 feeder cells having expression of factors capable of increasing activation and proliferation of natural killer cells, wherein the factors capable of increasing activation and proliferation of NK cells include: (A) a co-stimulatory molecule comprises CD80 molecules, and 4-1BBL molecules; and (B) a cytokine, specifically membrane-bound IL-21 (mbIL-21).